Published in Medical Letter on the CDC and FDA, June 1st, 2008
Results will be published in the July issue of Alcoholism: Clinical & Experimental Research and are currently available at OnlineEarly.
"In 1994, naltrexone was the first medication to be approved by the Food and Drug Administration for the treatment of AD," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.